rs74483926

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_170606.3(KMT2C):​c.10979C>T​(p.Ser3660Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0444 in 1,614,162 control chromosomes in the GnomAD database, including 2,196 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S3660S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.036 ( 158 hom., cov: 32)
Exomes 𝑓: 0.045 ( 2038 hom. )

Consequence

KMT2C
NM_170606.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 1.97

Publications

30 publications found
Variant links:
Genes affected
KMT2C (HGNC:13726): (lysine methyltransferase 2C) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
KMT2C Gene-Disease associations (from GenCC):
  • Kleefstra syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015626252).
BP6
Variant 7-152162598-G-A is Benign according to our data. Variant chr7-152162598-G-A is described in ClinVar as Benign. ClinVar VariationId is 134792.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.158 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2CNM_170606.3 linkc.10979C>T p.Ser3660Leu missense_variant Exon 43 of 59 ENST00000262189.11 NP_733751.2 Q8NEZ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2CENST00000262189.11 linkc.10979C>T p.Ser3660Leu missense_variant Exon 43 of 59 1 NM_170606.3 ENSP00000262189.6 Q8NEZ4-1

Frequencies

GnomAD3 genomes
AF:
0.0359
AC:
5462
AN:
152174
Hom.:
159
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00866
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.0256
Gnomad ASJ
AF:
0.0233
Gnomad EAS
AF:
0.167
Gnomad SAS
AF:
0.0770
Gnomad FIN
AF:
0.0308
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0429
Gnomad OTH
AF:
0.0344
GnomAD2 exomes
AF:
0.0477
AC:
11984
AN:
251438
AF XY:
0.0497
show subpopulations
Gnomad AFR exome
AF:
0.00689
Gnomad AMR exome
AF:
0.0236
Gnomad ASJ exome
AF:
0.0225
Gnomad EAS exome
AF:
0.173
Gnomad FIN exome
AF:
0.0333
Gnomad NFE exome
AF:
0.0400
Gnomad OTH exome
AF:
0.0347
GnomAD4 exome
AF:
0.0453
AC:
66282
AN:
1461870
Hom.:
2038
Cov.:
33
AF XY:
0.0463
AC XY:
33697
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.00556
AC:
186
AN:
33480
American (AMR)
AF:
0.0233
AC:
1044
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0224
AC:
586
AN:
26136
East Asian (EAS)
AF:
0.172
AC:
6832
AN:
39700
South Asian (SAS)
AF:
0.0697
AC:
6009
AN:
86242
European-Finnish (FIN)
AF:
0.0305
AC:
1627
AN:
53420
Middle Eastern (MID)
AF:
0.0284
AC:
164
AN:
5768
European-Non Finnish (NFE)
AF:
0.0424
AC:
47136
AN:
1112004
Other (OTH)
AF:
0.0447
AC:
2698
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
4078
8156
12234
16312
20390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1858
3716
5574
7432
9290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0359
AC:
5462
AN:
152292
Hom.:
158
Cov.:
32
AF XY:
0.0370
AC XY:
2757
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00864
AC:
359
AN:
41570
American (AMR)
AF:
0.0256
AC:
391
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0233
AC:
81
AN:
3472
East Asian (EAS)
AF:
0.167
AC:
863
AN:
5176
South Asian (SAS)
AF:
0.0766
AC:
369
AN:
4816
European-Finnish (FIN)
AF:
0.0308
AC:
327
AN:
10616
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0430
AC:
2922
AN:
68020
Other (OTH)
AF:
0.0364
AC:
77
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
258
516
774
1032
1290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0433
Hom.:
679
Bravo
AF:
0.0352
TwinsUK
AF:
0.0418
AC:
155
ALSPAC
AF:
0.0467
AC:
180
ESP6500AA
AF:
0.00908
AC:
40
ESP6500EA
AF:
0.0383
AC:
329
ExAC
AF:
0.0477
AC:
5788
Asia WGS
AF:
0.0960
AC:
333
AN:
3478
EpiCase
AF:
0.0413
EpiControl
AF:
0.0374

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 30, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24965397) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
3.8
DANN
Benign
0.35
DEOGEN2
Benign
0.12
T;T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.34
N
LIST_S2
Benign
0.68
.;T;T
MetaRNN
Benign
0.0016
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N;N;.
PhyloP100
2.0
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-1.8
N;N;N
REVEL
Benign
0.26
Sift
Benign
0.36
T;T;T
Sift4G
Benign
0.78
.;.;T
Polyphen
0.0020
B;B;.
Vest4
0.067
MPC
0.070
ClinPred
0.014
T
GERP RS
1.7
Varity_R
0.060
gMVP
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74483926; hg19: chr7-151859683; COSMIC: COSV51370572; COSMIC: COSV51370572; API